Efficacy of a novel oral carbapenem, tebipenem pivoxil (TBM-PI), against experimental otitis media caused by penicillin resistant Streptococcus pneumoniae in chinchilla

Vaccine

Volumn 25, Issue 13, 2007, Pages 2478-2484

  Hotomi, Muneki ^a   Suzumoto, Masaki ^a   Itahashi, Koju ^b   Nagura, Jun ^b   Fukushima, Takayoshi ^b   Shimada, Jun ^a   Billal, Dewan S ^a   Yamauchi, Kazuma ^a   Fujihara, Keiji ^a   Yamanaka, Noboru ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

Chinchilla; Experimental otitis media; Streptococcus pneumoniae; Tebipenem pivoxil

Indexed keywords

AMOXICILLIN; CARBAPENEM; PENICILLIN G; TEBIPENEM PIVOXIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CULTURE; CHINCHILLA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; MALE; MIDDLE EAR EFFUSION; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE;

ADMINISTRATION, ORAL; AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CHINCHILLA; MALE; MODELS, ANIMAL; OTITIS MEDIA; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 33847617396     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.09.023     Document Type: Article

References (27)

1. Teele D.W., Klein J.O., and Rosener B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective cohort study. J Infect Dis 160 (1989) 83-94
2. Chonmaitree T., and Howie V.M. Bacteriology of acute otitis media. In: Bernstein J., and Ogra P.L. (Eds). Immunology of otitis media-1987 (1987), Raven Press, New York 231-247
3. Klein J.O. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 12 (1993) 973-975
4. Bluestone C.D., Stephenson J.S., and Martin L.M. Ten-years review of otitis media pathogens. Pediatr Infect Dis J 11 8 (1992) S7-S11
5. Alper C.M., Doyle W.J., Seroky J.T., and Bluestone C.D. Ampicillin and amoxicillin treatment of acute otitis media caused by penicillin sensitive, intermediate and resistant Streptococcus pneumoniae infection in the chinchilla. In: Lim D., Bluestone C.D., and Casselbrant M.L. (Eds). Proceeding of sixth international symposium on recent advances in otitis media. Toronto, BC: Decker Inc. (1996)
6. Rosenfeld R.M., Vertrees J.E., Carr J., Cipolle R.J., Uden D.J., Giebink G.S., et al. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr 124 (1994) 355-367
7. Bluestone C.D., and Klein J.O. Otitis media in infants and children. 2nd ed. (1994), W.B. Saunders, Philadelphia
8. Mason Jr. E.O., Laplan S.L., Lamberth L.B., and Tillman J. Increased rte of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother 36 (1992) 1703-1707
9. Hotomi M., Yamanaka N., Samukawa T., Suzumoto M., Sakai A., Shimada J., et al. Treatment and outcome of severe and non-severe acute otitis media. Eur J Pediatr 164 (2005) 3-8
10. Hotomi M., Yamanaka N., Shimada J., Ikeda Y., and Faden H. Factors associated with clinical outcomes in acute otitis media. Ann Otol Rhinol Laryngol 113 (2004) 846-852
11. Hotomi M., Billal D.S., Shimada J., Suzumoto M., Yamauchi K., Fujihara K., et al. High prevalence of Streptococcus pneumoniae with mutations in pbp1a, pbp2x, and pbp2b genes of penicillin-binding proteins in the nasopharynx in children in Japan. ORL J Otorhinolaryngol Relat Spec 68 (2006) 139-145
12. Hotomi M., Bilal D.S., Shimada J., Suzumoto M., Yamauchi K., Fujihara K., et al. Increase of macrolide-resistant Streptococcus pneumoniae-expressing mefE or ermB gene in the nasopharynx among children with otitis media. Laryngoscope 115 (2005) 317-320
13. Hotomi M., Yamanaka N., Faden H., Shimada J., Suzumoto M., Sakai A., et al. Nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae in children with acute otitis media evaluated by polymerase chain reaction-based genotyping of penicillin-binding proteins. Acta Otolaryngol 122 (2002) 72-77
14. Birnbaum J., Kahan F.M., Kropp H., and MacDonald J.S. Carbapenems, a new class of beta-lactam antibiotics. Am J Med 78 6A (1985) 3-21
15. Mitsuhashi S. In vitro and in vivo antibacterial activity of imipenem against clinical isolates of bacteria. J Antimicrob Chemother 12 D (1983) 53-64
16. Neu H.C., Chin N.X., Saha G., and Labthavikul P. In vitro activity against aerobic and anaerobic gram-positive ad gram negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem. Antimicrob Agents Chemother 30 (1986) 828-834
17. Edwards J.R. Meropenem: a microbiological overview. J Antimicrob Chemother 6(A) (1995) 1-17
18. Kobayashi R., Konomi M., Hasegawa K., Morozumi M., Sunakawa K., and Ubukata K. In vitro activity of tebipenem, a new oral carbapenem antibiotic, against penicillin-nonsusceptible Streptococcus pneumoniae. Antimicrob Agents Chemother 49 (2005) 889-894
19. Hikida M., Itahashi K., Igarashi A., Shiba T., and Kitamura M. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity. Antimicrob Agents Chemother 43 (1999) 2010-2016
20. Barry B., Muffat-Joly M., Gehanno P., and Pocidalo J.J. Effect of increased dosages of amoxicillin in treatment of experimental middle ear otitis due to penicillin resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 37 (1993) 1599-1603
21. Faden H., Bernstein J.M., Brodsky L., Stanievich J., and Ogra P.L. Effect of prior antibiotic treatment on middle ear disease in children. Ann Otol Rhinol Laryngol 101 (1992) 87-91
22. McCracken Jr. G.H. Selection of antimicrobial agents for treatment of acute otitis media with effusion. Pediatr Infect Dis J 6 (1987) 985-988
23. Rosenfeld R.M., Doyle W.J., Swarts J.D., Seroky J.T., and Green I. Efficacy of ceftibuten for acute otitis media caused by Haemophilus influenzae: an animal study. Ann Otol Rhinol Laryngol 102 (1993) 222-226
24. Chan K.H., Swart J.D., Doyle W.J., Tanpowpong K., and Kardatzke D.R. Efficacy of a new macrolide (azithromycin) for acute otitis media in the chinchilla model. Arch Otolaryngol 114 (1992) 1266-1269
25. Babl F.E., Pelton S.I., and Li Z. Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo. Antimicrob Agents Chemother 46 (2002) 2194-2199
26. Pelton S.I., Figueira M., Albut R., and Stalker D. Efficacy of linezolid in experimental otitis media. Antimicrob Agents Chemother 44 (2000) 654-657
27. Alper C.M., Doyle W.J., Seroky J.T., and Bluestone C.D. Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla. Antimicrob Agents Chemother 40 (1996) 1889-1892